BackMarksans Pharma Limited Overview
Marksans Pharma Limited

Marksans Pharma Limited Return on Equity

Valuation check: MARKSANS.NS's ROE is 16.8%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

16.80%

Return on Equity

16.80%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Marksans Pharma Limited (MARKSANS.NS) FAQ

As of the most recent data, MARKSANS.NS shows a ROE of 16.8%. That is above the sector sector average of 11.3%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.3%. Marksans Pharma Limited is at 16.8%, which is higher that average. That is roughly 48.7% above the sector mean. Use the comparison chart on this page to see how MARKSANS.NS stacks up against individual peers as well.

Check the historical chart to see whether MARKSANS.NS's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Marksans Pharma Limited with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Marksans Pharma Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 16.8%) with ownership activity and broader fundamentals.

Questions & Answers